BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22234205)

  • 1. Dual pathology of corticobasal degeneration and Parkinson's disease in a patient with clinical features of progressive supranuclear palsy.
    Mooney T; Tampiyappa A; Robertson T; Grimley R; Burke C; Ng K; Patrikios P
    Neurol India; 2011; 59(6):887-90. PubMed ID: 22234205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
    Kertesz A; McMonagle P
    J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
    Josephs KA; Duffy JR
    Curr Opin Neurol; 2008 Dec; 21(6):688-92. PubMed ID: 18989114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic challenge of corticobasal degeneration: distinction between clinical syndrome and pathology].
    Kellner O; Sabova K; Neumann M; Jung HH
    Fortschr Neurol Psychiatr; 2011 Nov; 79(11):660-7. PubMed ID: 22009274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurrence of radiological features of progressive supranuclear palsy and corticobasal degeneration.
    Divatia R; Khan F; Kishore A
    Neurol India; 2007; 55(1):75-7. PubMed ID: 17272907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurrence of Parkinson's disease with progressive supranuclear palsy.
    Judkins AR; Forman MS; Uryu K; Hinkle DA; Asbury AK; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2002 May; 103(5):526-30. PubMed ID: 11935271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical corticobasal degeneration with clinical pictures of Parkinson's disease--an L-dopa-effective case].
    Kagamihara Y
    Brain Nerve; 2007 Jun; 59(6):637-45. PubMed ID: 17585597
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary progressive freezing gait: a syndrome with many causes.
    Factor SA; Higgins DS; Qian J
    Neurology; 2006 Feb; 66(3):411-4. PubMed ID: 16476942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The many faces of corticobasal degeneration.
    Wadia PM; Lang AE
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S336-40. PubMed ID: 18267261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
    Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
    Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropathology of corticobasal degeneration].
    Wakabayashi K; Takahashi H
    No To Shinkei; 1996 Jun; 48(6):521-32. PubMed ID: 8703555
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
    Hauw JJ; Hausser-Hauw C; Duyckaerts C
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.